Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04770909 · ClinicalTrials.gov registry record · NA
Log2Lose: Incenting Weight Loss and Dietary Self-monitoring in Real-time to Improve Weight Management Among Adults With Obesity
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 706
- Enrollment target
NCT04770909: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT04770909 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 706 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04770909, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 706 participants
- Enrollment target
Study Summary
This study involves an evaluation of whether providing small incentives weekly for dietary self-monitoring and/or weight loss improves short- and long-term weight loss. Participants can expect to be on study for 18 months.
Primary Outcome
Measured on a calibrated, digital scale to the nearest 0.1 kg
Interventions
- BEHAVIORAL Incentives for dietary self-monitoring and weight loss
- BEHAVIORAL Incentives for dietary self-monitoring
- BEHAVIORAL Incentives for weight loss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 706 participants |
| Start Date | 2021-05-13 |
| Est. Completion | 2025-04-10 |
| Phase | NA |
What the finished NCT04770909 record still lists
NCT04770909 is an interventional study that assigns participants to a tested intervention. The registered 706 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 3 interventions - of which Incentives for dietary self-monitoring and weight loss is the first listed.
NCT04770909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04770909 about?
NCT04770909 is a clinical study titled "Log2Lose: Incenting Weight Loss and Dietary Self-monitoring in Real-time to Improve Weight Management Among Adults With Obesity". This study involves an evaluation of whether providing small incentives weekly for dietary self-monitoring and/or weight loss improves short- and long-term weight loss. Participants can expect to be on study for 18 months.
What is the current status of trial NCT04770909?
This trial is currently completed. It is a NA study. The enrollment target is 706 participants. The study started on 2021-05-13. Estimated completion is 2025-04-10.
What interventions are being tested in trial NCT04770909?
The interventions under investigation include: Incentives for dietary self-monitoring and weight loss (BEHAVIORAL), Incentives for dietary self-monitoring (BEHAVIORAL), Incentives for weight loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT04770909?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04770909's enrollment target sits among peer trials
706 148th of 2000 higher than 1,853 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06480383 · 705 participants · Phase 2
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- NCT07067463 · 705 participants · Phase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- NCT05796687 · 704 participants · NA
Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings
- NCT06350734 · 704 participants
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI